C3'-deoxygenation of aminoglycosides results in their decreased susceptibility to phosphorylation thereby increasing their efficacy as antibiotics.H owever,t he biosynthetic mechanism of C3'-deoxygenation is unknown. To address this issue,aprD4 and aprD3 genes from the apramycin gene cluster in Streptomyces tenebrarius were expressed in E. coli and the resulting gene products were characterized in vitro.AprD4 is shown to be aradical S-adenosylmethionine (SAM) enzyme,c atalyzing homolysis of SAM to 5'-deoxyadenosine (5'-dAdo) in the presence of paromamine.[ 4 '-2
Oxetanocin A and albucidin are two oxetane natural products. While the biosynthesis of oxetanocin A has been described, less is known about albucidin. In this work, the albucidin biosynthetic gene cluster is identified in Streptomyces. Heterologous expression in a nonproducing strain demonstrates that the genes alsA and alsB are necessary and sufficient for albucidin biosynthesis confirming a previous study (Myronovskyi et al. Microorganisms 2020, 8, 237). A two-step construction of albucidin 4'-phosphate from 2'-deoxyadenosine monophosphate (2'-dAMP) is shown to be catalyzed in vitro by the cobalamin dependent radical Sadenosyl-L-methionine (SAM) enzyme AlsB, which catalyzes a ring contraction, and the radical SAM enzyme AlsA, which catalyzes elimination of a onecarbon fragment. Isotope labelling studies show that AlsB catalysis begins with stereospecific H-atom transfer of the C2'-pro-R hydrogen from 2'-dAMP to 5'deoxyadenosine, and that the eliminated one-carbon fragment originates from C3' of 2'-dAMP.
OxsB is a B12-dependent radical SAM enzyme
that catalyzes
the oxidative ring contraction of 2′-deoxyadenosine 5′-phosphate
to the dehydrogenated, oxetane containing precursor of oxetanocin
A phosphate. AlsB is a homologue of OxsB that participates in a similar
reaction during the biosynthesis of albucidin. Herein, OxsB and AlsB
are shown to also catalyze radical mediated, stereoselective C2′-methylation
of 2′-deoxyadenosine monophosphate. This reaction proceeds
with inversion of configuration such that the resulting product also
possesses a C2′ hydrogen atom available for abstraction. However,
in contrast to methylation, subsequent rounds of catalysis result
in C–C dehydrogenation of the newly added methyl group to yield
a 2′-methylidene followed by radical addition of a 5′-deoxyadenosyl
moiety to produce a heterodimer. These observations expand the scope
of reactions catalyzed by B12-dependent radical SAM enzymes
and emphasize the susceptibility of radical intermediates to bifurcation
along different reaction pathways even within the highly organized
active site of an enzyme.
Oxetanocin A and albucidin are two oxetane natural products. While the biosynthesis of oxetanocin A has been described, less is known about albucidin. In this work, the albucidin biosynthetic gene cluster is identified in Streptomyces. Heterologous expression in a nonproducing strain demonstrates that the genes alsA and alsB are necessary and sufficient for albucidin biosynthesis confirming a previous study (Myronovskyi et al. Microorganisms 2020, 8, 237). A two‐step construction of albucidin 4′‐phosphate from 2′‐deoxyadenosine monophosphate (2′‐dAMP) is shown to be catalyzed in vitro by the cobalamin dependent radical S‐adenosyl‐l‐methionine (SAM) enzyme AlsB, which catalyzes a ring contraction, and the radical SAM enzyme AlsA, which catalyzes elimination of a one‐carbon fragment. Isotope labelling studies show that AlsB catalysis begins with stereospecific H‐atom transfer of the C2′‐pro‐R hydrogen from 2′‐dAMP to 5′‐deoxyadenosine, and that the eliminated one‐carbon fragment originates from C3′ of 2′‐dAMP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.